Additionally, patients with Stage IV tumors exhibited higher PD-L1 expression compared to Stage I–III cases, especially in brain metastases, which may indicate a more immunosuppressive tumor microenvironment, facilitating tumor progression and immune evasion. Here, CD274 is linked to neoplasm.